Brokerages Set IMS Health Holdings Inc. (NYSE:IMS) Target Price at $31.00
IMS Health Holdings Inc. (NYSE:IMS) has been given an average recommendation of “Buy” by the ten brokerages that are presently covering the stock. Three research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $31.00.
IMS has been the subject of several research reports. Zacks Investment Research raised shares of IMS Health Holdings from a “hold” rating to a “buy” rating and set a $34.00 price objective for the company in a research note on Wednesday, September 28th. TheStreet downgraded shares of IMS Health Holdings from a “buy” rating to a “hold” rating in a research note on Monday, August 29th.
Large investors have recently bought and sold shares of the company. Brahman Capital Corp. purchased a new stake in IMS Health Holdings during the second quarter valued at $182,918,000. Farallon Capital Management LLC boosted its stake in IMS Health Holdings by 107.0% in the second quarter. Farallon Capital Management LLC now owns 6,347,206 shares of the company’s stock valued at $160,965,000 after buying an additional 3,281,134 shares during the period. Janus Capital Management LLC boosted its stake in IMS Health Holdings by 56.2% in the second quarter. Janus Capital Management LLC now owns 7,289,684 shares of the company’s stock valued at $184,864,000 after buying an additional 2,622,297 shares during the period. BlueMountain Capital Management LLC boosted its stake in IMS Health Holdings by 10,293.4% in the first quarter. BlueMountain Capital Management LLC now owns 1,792,650 shares of the company’s stock valued at $47,595,000 after buying an additional 1,775,402 shares during the period. Finally, Steinberg Asset Management LLC purchased a new stake in IMS Health Holdings during the second quarter valued at $20,995,000. Institutional investors own 90.25% of the company’s stock.
IMS Health Holdings (NYSE:IMS) opened at 31.34 on Monday. The company’s 50-day moving average is $29.94 and its 200-day moving average is $27.44. IMS Health Holdings has a one year low of $22.36 and a one year high of $31.59. The firm has a market cap of $10.32 billion, a PE ratio of 76.07 and a beta of 0.83.
IMS Health Holdings (NYSE:IMS) last issued its quarterly earnings data on Wednesday, July 27th. The company reported $0.41 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.38 by $0.03. The business earned $802 million during the quarter, compared to the consensus estimate of $796.93 million. IMS Health Holdings had a net margin of 4.45% and a return on equity of 30.61%. The firm’s revenue was up 112.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.37 EPS. On average, analysts forecast that IMS Health Holdings will post $1.64 earnings per share for the current fiscal year.
About IMS Health Holdings
IMS Health Holdings, Inc (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.
Receive News & Ratings for IMS Health Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMS Health Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.